A Study to Compare the Titration Efficacy and Safety of Control-released Oxycodone and Immediate-released Oxycodone in Patients With Moderate to Severe Cancer Pain

NCT03176199 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Cancer
Pain

Interventions

DRUG: Oxycodone
DRUG: Oxycodone

Sponsor

Taiwan Mundipharma Pharmaceuticals Ltd.